Caribou Biosciences, Inc. (CRBU) Tops Q3 EPS by 7c

Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q3 EPS of ($0.38), $0.07 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $2.02 million versus the consensus estimate of $3.08 million.

For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.

You May Also Be Interested In

• Kalshi in early talks for IPO - The Information
• Alamos Gold Inc. (AGI:CN) (AGI) PT Lowered to Cdn$73 at BMO Capital
• JPMorgan Upgrades Sika AG (SIKA:SW) (SKFOF) to Neutral